Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $129.21 million. The enterprise value is $71.74 million.
Important Dates
The last earnings date was Tuesday, February 24, 2026, after market close.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 68.36 million shares outstanding. The number of shares has increased by 40.28% in one year.
| Current Share Class | 68.36M |
| Shares Outstanding | 68.36M |
| Shares Change (YoY) | +40.28% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 40.00% |
| Float | 66.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 217.89 |
| Forward PS | 395.86 |
| PB Ratio | 2.84 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 120.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.67 |
| Quick Ratio | 3.59 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.45% and return on invested capital (ROIC) is -46.83%.
| Return on Equity (ROE) | -71.45% |
| Return on Assets (ROA) | -38.47% |
| Return on Invested Capital (ROIC) | -46.83% |
| Return on Capital Employed (ROCE) | -107.63% |
| Weighted Average Cost of Capital (WACC) | 11.57% |
| Revenue Per Employee | $19,129 |
| Profits Per Employee | -$1.48M |
| Employee Count | 31 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.42% in the last 52 weeks. The beta is 1.34, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -55.42% |
| 50-Day Moving Average | 2.30 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 49.59 |
| Average Volume (20 Days) | 834,253 |
Short Selling Information
The latest short interest is 17.98 million, so 26.30% of the outstanding shares have been sold short.
| Short Interest | 17.98M |
| Short Previous Month | 17.19M |
| Short % of Shares Out | 26.30% |
| Short % of Float | 26.95% |
| Short Ratio (days to cover) | 11.08 |
Income Statement
In the last 12 months, CRDF had revenue of $593,000 and -$45.88 million in losses. Loss per share was -$0.69.
| Revenue | 593,000 |
| Gross Profit | -1.78M |
| Operating Income | -48.96M |
| Pretax Income | -45.85M |
| Net Income | -45.88M |
| EBITDA | -48.60M |
| EBIT | -48.96M |
| Loss Per Share | -$0.69 |
Full Income StatementBalance Sheet
The company has $58.30 million in cash and $832,000 in debt, with a net cash position of $57.47 million or $0.84 per share.
| Cash & Cash Equivalents | 58.30M |
| Total Debt | 832,000 |
| Net Cash | 57.47M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 45.39M |
| Book Value Per Share | 0.66 |
| Working Capital | 43.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$37.92 million and capital expenditures -$44,000, giving a free cash flow of -$37.97 million.
| Operating Cash Flow | -37.92M |
| Capital Expenditures | -44,000 |
| Free Cash Flow | -37.97M |
| FCF Per Share | -$0.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -8,256.32% |
| Pretax Margin | -7,732.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.28% |
| Shareholder Yield | -40.28% |
| Earnings Yield | -35.51% |
| FCF Yield | -29.38% |
Analyst Forecast
The average price target for CRDF is $9.63, which is 409.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.63 |
| Price Target Difference | 409.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 259.33% |
| EPS Growth Forecast (5Y) | -12.25% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of -4.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.19 |
| Piotroski F-Score | 1 |
